AskTheDate.com
Back to calendar

Larimar Therapeutics, Inc. (LRMR) Earnings

LRMR reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.35
Actual EPS: $-0.30
Company overview
Market Cap$394.5M
SectorHealth Technology
IndustryBiotechnology
Buy me a coffee